Drug Topics
NOVEMBER 3, 2023
Attendees at an AMCP Nexus session received an overview of FDA approvals granted in 2023 as well as a preview of nononcology drugs to be released over the next 5 years.
Pharmacy Times
NOVEMBER 3, 2023
It is crucial to continue to evolve from dependent prescribing to an independent model, and address barriers with opportunities for change.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
NOVEMBER 3, 2023
Ravi Patel, PharmD, MBA, MS, discusses how artificial intelligence can be a benefit to both patients and community pharmacies.
Pharmacy Times
NOVEMBER 3, 2023
In most patients who are pregnant or may become pregnant, warfarin is contraindicated due to increased risk of adverse fetal outcomes.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
NOVEMBER 3, 2023
During a session at AMCP Nexus, presenters discussed the delicate balance between cost and innovation as it relates to forthcoming oncology treatments.
STAT
NOVEMBER 3, 2023
More than 10 million people were disenrolled from Medicaid over the past six months, according to the latest data published by a KFF tracker. The tracker has collected data on Medicaid enrollment since the first states began redetermining eligibility in April, after the expiration of the federal requirement of continuous coverage during the Covid-19 public health emergency.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
NOVEMBER 3, 2023
’Tis the season — open enrollment season, that is. Since before the Nov. 1 start to the annual open enrollment period, the advertising engines for state health insurance marketplaces, and the federal exchange, healthcare.gov , have been revving up. The nation’s uninsurance rate is down to 7.7% — the lowest it has ever been.
Fierce Healthcare
NOVEMBER 3, 2023
House Democrats are pressuring Centers for Medicare and Medicaid Services to better evaluate how AI is utilized by Medicare Advantage plans, hoping to prevent eye-catching rates of denial. | Medicare Advantage prior authorization denials are in the crosshairs of House Democrats. They say evidence points toward insurers willingly allowing algorithms to wrongfully deny service to patients.
STAT
NOVEMBER 3, 2023
I was living on the precipice of end-stage disease when I enrolled in the clinical trial that resulted in the historically fast Food and Drug Administration approval for the game-changing cystic fibrosis drug Trikafta. Five years later, the worst parts of my CF are gone. I recently recovered from a viral infection that provoked a pneumonia-like illness without landing in a hospital tied to an oxygen tank.
Fierce Pharma
NOVEMBER 3, 2023
Pfizer’s plunging COVID-19 product demand has spurred a companywide cost-cutting campaign, with nearly 200 jobs now on the chopping block in Michigan. | Pfizer is cutting roughly 200 positions at its Kalamazoo site following a review of demand for its COVID-19 vaccine and antiviral Comirnaty and Paxlovid.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
NOVEMBER 3, 2023
Coca notes the importance of precision medicine in CKD risk assessment and describes the potential impact multiple therapies can have on future CKD prediction and treatment in the future.
STAT
NOVEMBER 3, 2023
How old is Claire Snyman? “I am now…” she says with pause. “I always have to think. I have a brain injury as a result of my surgery, so many of these things do not come naturally to me.” The thought arrives. She is 47. But on this day in late August, there’s a more important anniversary: 11 years since doctors removed an expanding mass from her brain.
Pharmacy Times
NOVEMBER 3, 2023
On this month's episode, Pharmacy Times covers the Academy of Managed Care Pharmacy Nexus 2023 conference, highlighting the updates on biosimilars.
PharmaVoice
NOVEMBER 3, 2023
From biotech startups to a services agency, these entrepreneurs are hedging their bets to offer innovative approaches in patient care.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
NOVEMBER 3, 2023
In an article by The New England Journal of Medicine, the authors discuss how drug companies could delay the approval of new oncology drugs under the IRA, delaying patient care.
STAT
NOVEMBER 3, 2023
The federal government is moving forward with a spate of proposals that will force hospitals to be better about publishing the prices they charge health insurers and patients. Federal law has required hospitals to post their prices since 2021. Compliance has been dismal , although it has improved since the government increased fines a few years ago.
Pharmacy Times
NOVEMBER 3, 2023
Nephrotoxic care can be improved with better risk score assessment and provider education.
STAT
NOVEMBER 3, 2023
Most of the formularies run by some of the largest health plans in the U.S. generally provide “fair access” to 18 treatments for a handful of serious diseases, although transparent coverage information is often lacking for some medicines, a new analysis has found. Almost uniformly, the 19 formularies made the medicines available fairly when judged on three criteria: eligibility based on clinical data, restrictions placed on prescribers, and step therapy, which requires patients to
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
NOVEMBER 3, 2023
Insurance policies are notoriously known for red tape and processes that burden both doctors and patients. | The time-sensitive GI procedures that UHC is targeting with prior authorization are critical in helping to detect, treat, and monitor a range of diseases that impact millions of Americans.
The Checkup by Singlecare
NOVEMBER 3, 2023
“If you keep eating like that, you’re going to get diabetes.” If you’ve ever been scolded like this for enjoying a sugar-laden dessert, know that an occasional confection isn’t going to send you immediately into poor health. However, it is important to understand the consequences of the nutritional choices that you make, such as a diet that includes excessive amounts of added sugar.
Fierce Healthcare
NOVEMBER 3, 2023
Innovation is often measured and marked by disruption – particularly in healthcare. | Innovation is often measured and marked by disruption – particularly in healthcare.
pharmaphorum
NOVEMBER 3, 2023
Study finds higher cancer rate in patients given ‘all clear’ Phil.
Fierce Healthcare
NOVEMBER 3, 2023
Among a rush of new changes in 2024, Independence Blue Cross is introducing new health plans, increased access to virtual care and in-network dental plans. | Independence Blue Cross is prioritizing three new health plans and virtual care as part its batch of offerings heading into 2024.
Drug Store News
NOVEMBER 3, 2023
John Driscoll, executive vice president and president of U.S. healthcare at Walgreens Boots Alliance, discusses the company’s vision for the future of health care.
pharmaphorum
NOVEMBER 3, 2023
Scientists in the C-Suite: Attracting investors takes more than good science Mike.
Drug Store News
NOVEMBER 3, 2023
Since the program's inception in 2021, more than $10 million have gone to nonprofits—all chosen by Meijer team members across the Midwest.
pharmaphorum
NOVEMBER 3, 2023
Moderna swings to loss as COVID sales slump Phil.
PharmExec
NOVEMBER 3, 2023
Due to a global demand, treatments such as Adderall and Ritalin have been in short supply for the management of attention-deficit hyperactivity disorder.
European Pharmaceutical Review
NOVEMBER 3, 2023
The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Pfizer’s Litfulo (ritlecitinib) for treatment for severe alopecia areata in patients 12 years and older. A hard capsule medicine, Litfulo is recommended to be taken daily as one 50mg oral dose. Litfulo’s active ingredient, ritlecitinib, is an enzyme inhibitor. It works irreversibly and selectively inhibits Janus kinase 3 (JAK3) and the tyrosine (TEC) family of kinases by blocking γ-common cytokine signalling and reduc
pharmaphorum
NOVEMBER 3, 2023
Lexeo files $100m IPO in tough listing environment Phil.
STAT
NOVEMBER 3, 2023
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. Please note that our regular feature — in which we spotlight someone — will return next week.
The Thyroid Pharmacist
NOVEMBER 3, 2023
Got reflux? I had reflux, too. It started with a chronic cough, pain, burning, and choking sensation. I tried every over-the-counter product possible. I saw my primary care doctor, an allergist, a gastroenterologist, and an ear, nose, and throat doctor. I even had a barium swallow test where I swallowed a nasty, chalky substance, and the test revealed I had a sliding hiatal hernia with spontaneous reflux.
STAT
NOVEMBER 3, 2023
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda, so far, is exceedingly modest. We will attempt to employ a new device for moving leaves about the official grounds, catch up on our reading and perhaps hold another listening party.
Expert insights. Personalized for you.
281 
Let's personalize your content